[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Coagulation Factor Concentrates Market Growth 2022-2028

January 2022 | 107 pages | ID: GE298B8ACD5DEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Coagulation Factor Concentrates will have significant change from previous year. According to our (LP Information) latest study, the global Coagulation Factor Concentrates market size is USD million in 2022 from USD 6320.6 million in 2021, with a change of % between 2021 and 2022. The global Coagulation Factor Concentrates market size will reach USD 9671.9 million in 2028, growing at a CAGR of 6.3% over the analysis period.

The United States Coagulation Factor Concentrates market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Coagulation Factor Concentrates market, reaching US$ million by the year 2028. As for the Europe Coagulation Factor Concentrates landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Coagulation Factor Concentrates players cover CSL (Australia), Grifols (Spain), Shire (Ireland), and Octapharma (Switzerland), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Coagulation Factor Concentrates market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Factor VIII
  • Factor IX
  • Von Willebrand Factor
  • Prothrombin Complex Concentrates
  • Fibrinogen Concentrates
  • Factor XIII
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Neurology
  • Immunology
  • Hematology
  • Critical Care
  • Pulmonology
  • Hemato-Oncology
  • Rheumatology
  • Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • CSL (Australia)
  • Grifols (Spain)
  • Shire (Ireland)
  • Octapharma (Switzerland)
  • Kedrion (Italy)
  • Bio Product Laboratory (UK)
  • Sanquin (Netherlands)
  • LFB (France)
  • Biotest (Germany)
  • Japan Blood Products Organization, China Biologic Products (China)
  • Green Cross Corporation (South Korea)
  • Shanghai RAAS Blood Products (China)
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Coagulation Factor Concentrates Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Coagulation Factor Concentrates by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Coagulation Factor Concentrates by Country/Region, 2017, 2022 & 2028
2.2 Coagulation Factor Concentrates Segment by Type
  2.2.1 Factor VIII
  2.2.2 Factor IX
  2.2.3 Von Willebrand Factor
  2.2.4 Prothrombin Complex Concentrates
  2.2.5 Fibrinogen Concentrates
  2.2.6 Factor XIII
2.3 Coagulation Factor Concentrates Sales by Type
  2.3.1 Global Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)
  2.3.2 Global Coagulation Factor Concentrates Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Coagulation Factor Concentrates Sale Price by Type (2017-2022)
2.4 Coagulation Factor Concentrates Segment by Application
  2.4.1 Neurology
  2.4.2 Immunology
  2.4.3 Hematology
  2.4.4 Critical Care
  2.4.5 Pulmonology
  2.4.6 Hemato-Oncology
  2.4.7 Rheumatology
  2.4.8 Others
2.5 Coagulation Factor Concentrates Sales by Application
  2.5.1 Global Coagulation Factor Concentrates Sale Market Share by Application (2017-2022)
  2.5.2 Global Coagulation Factor Concentrates Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Coagulation Factor Concentrates Sale Price by Application (2017-2022)

3 GLOBAL COAGULATION FACTOR CONCENTRATES BY COMPANY

3.1 Global Coagulation Factor Concentrates Breakdown Data by Company
  3.1.1 Global Coagulation Factor Concentrates Annual Sales by Company (2020-2022)
  3.1.2 Global Coagulation Factor Concentrates Sales Market Share by Company (2020-2022)
3.2 Global Coagulation Factor Concentrates Annual Revenue by Company (2020-2022)
  3.2.1 Global Coagulation Factor Concentrates Revenue by Company (2020-2022)
  3.2.2 Global Coagulation Factor Concentrates Revenue Market Share by Company (2020-2022)
3.3 Global Coagulation Factor Concentrates Sale Price by Company
3.4 Key Manufacturers Coagulation Factor Concentrates Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Coagulation Factor Concentrates Product Location Distribution
  3.4.2 Players Coagulation Factor Concentrates Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR COAGULATION FACTOR CONCENTRATES BY GEOGRAPHIC REGION

4.1 World Historic Coagulation Factor Concentrates Market Size by Geographic Region (2017-2022)
  4.1.1 Global Coagulation Factor Concentrates Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Coagulation Factor Concentrates Annual Revenue by Geographic Region
4.2 World Historic Coagulation Factor Concentrates Market Size by Country/Region (2017-2022)
  4.2.1 Global Coagulation Factor Concentrates Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Coagulation Factor Concentrates Annual Revenue by Country/Region
4.3 Americas Coagulation Factor Concentrates Sales Growth
4.4 APAC Coagulation Factor Concentrates Sales Growth
4.5 Europe Coagulation Factor Concentrates Sales Growth
4.6 Middle East & Africa Coagulation Factor Concentrates Sales Growth

5 AMERICAS

5.1 Americas Coagulation Factor Concentrates Sales by Country
  5.1.1 Americas Coagulation Factor Concentrates Sales by Country (2017-2022)
  5.1.2 Americas Coagulation Factor Concentrates Revenue by Country (2017-2022)
5.2 Americas Coagulation Factor Concentrates Sales by Type
5.3 Americas Coagulation Factor Concentrates Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Coagulation Factor Concentrates Sales by Region
  6.1.1 APAC Coagulation Factor Concentrates Sales by Region (2017-2022)
  6.1.2 APAC Coagulation Factor Concentrates Revenue by Region (2017-2022)
6.2 APAC Coagulation Factor Concentrates Sales by Type
6.3 APAC Coagulation Factor Concentrates Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Coagulation Factor Concentrates by Country
  7.1.1 Europe Coagulation Factor Concentrates Sales by Country (2017-2022)
  7.1.2 Europe Coagulation Factor Concentrates Revenue by Country (2017-2022)
7.2 Europe Coagulation Factor Concentrates Sales by Type
7.3 Europe Coagulation Factor Concentrates Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Coagulation Factor Concentrates by Country
  8.1.1 Middle East & Africa Coagulation Factor Concentrates Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Coagulation Factor Concentrates Revenue by Country (2017-2022)
8.2 Middle East & Africa Coagulation Factor Concentrates Sales by Type
8.3 Middle East & Africa Coagulation Factor Concentrates Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Coagulation Factor Concentrates
10.3 Manufacturing Process Analysis of Coagulation Factor Concentrates
10.4 Industry Chain Structure of Coagulation Factor Concentrates

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Coagulation Factor Concentrates Distributors
11.3 Coagulation Factor Concentrates Customer

12 WORLD FORECAST REVIEW FOR COAGULATION FACTOR CONCENTRATES BY GEOGRAPHIC REGION

12.1 Global Coagulation Factor Concentrates Market Size Forecast by Region
  12.1.1 Global Coagulation Factor Concentrates Forecast by Region (2023-2028)
  12.1.2 Global Coagulation Factor Concentrates Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Coagulation Factor Concentrates Forecast by Type
12.7 Global Coagulation Factor Concentrates Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 CSL (Australia)
  13.1.1 CSL (Australia) Company Information
  13.1.2 CSL (Australia) Coagulation Factor Concentrates Product Offered
  13.1.3 CSL (Australia) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 CSL (Australia) Main Business Overview
  13.1.5 CSL (Australia) Latest Developments
13.2 Grifols (Spain)
  13.2.1 Grifols (Spain) Company Information
  13.2.2 Grifols (Spain) Coagulation Factor Concentrates Product Offered
  13.2.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Grifols (Spain) Main Business Overview
  13.2.5 Grifols (Spain) Latest Developments
13.3 Shire (Ireland)
  13.3.1 Shire (Ireland) Company Information
  13.3.2 Shire (Ireland) Coagulation Factor Concentrates Product Offered
  13.3.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Shire (Ireland) Main Business Overview
  13.3.5 Shire (Ireland) Latest Developments
13.4 Octapharma (Switzerland)
  13.4.1 Octapharma (Switzerland) Company Information
  13.4.2 Octapharma (Switzerland) Coagulation Factor Concentrates Product Offered
  13.4.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Octapharma (Switzerland) Main Business Overview
  13.4.5 Octapharma (Switzerland) Latest Developments
13.5 Kedrion (Italy)
  13.5.1 Kedrion (Italy) Company Information
  13.5.2 Kedrion (Italy) Coagulation Factor Concentrates Product Offered
  13.5.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Kedrion (Italy) Main Business Overview
  13.5.5 Kedrion (Italy) Latest Developments
13.6 Bio Product Laboratory (UK)
  13.6.1 Bio Product Laboratory (UK) Company Information
  13.6.2 Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Offered
  13.6.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Bio Product Laboratory (UK) Main Business Overview
  13.6.5 Bio Product Laboratory (UK) Latest Developments
13.7 Sanquin (Netherlands)
  13.7.1 Sanquin (Netherlands) Company Information
  13.7.2 Sanquin (Netherlands) Coagulation Factor Concentrates Product Offered
  13.7.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Sanquin (Netherlands) Main Business Overview
  13.7.5 Sanquin (Netherlands) Latest Developments
13.8 LFB (France)
  13.8.1 LFB (France) Company Information
  13.8.2 LFB (France) Coagulation Factor Concentrates Product Offered
  13.8.3 LFB (France) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 LFB (France) Main Business Overview
  13.8.5 LFB (France) Latest Developments
13.9 Biotest (Germany)
  13.9.1 Biotest (Germany) Company Information
  13.9.2 Biotest (Germany) Coagulation Factor Concentrates Product Offered
  13.9.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Biotest (Germany) Main Business Overview
  13.9.5 Biotest (Germany) Latest Developments
13.10 Japan Blood Products Organization, China Biologic Products (China)
  13.10.1 Japan Blood Products Organization, China Biologic Products (China) Company Information
  13.10.2 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Offered
  13.10.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Japan Blood Products Organization, China Biologic Products (China) Main Business Overview
  13.10.5 Japan Blood Products Organization, China Biologic Products (China) Latest Developments
13.11 Green Cross Corporation (South Korea)
  13.11.1 Green Cross Corporation (South Korea) Company Information
  13.11.2 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Offered
  13.11.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 Green Cross Corporation (South Korea) Main Business Overview
  13.11.5 Green Cross Corporation (South Korea) Latest Developments
13.12 Shanghai RAAS Blood Products (China)
  13.12.1 Shanghai RAAS Blood Products (China) Company Information
  13.12.2 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Offered
  13.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Revenue, Price and Gross Margin (2020-2022)
  13.12.4 Shanghai RAAS Blood Products (China) Main Business Overview
  13.12.5 Shanghai RAAS Blood Products (China) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Coagulation Factor Concentrates Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Coagulation Factor Concentrates Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Factor VIII
Table 4. Major Players of Factor IX
Table 5. Major Players of Von Willebrand Factor
Table 6. Major Players of Prothrombin Complex Concentrates
Table 7. Major Players of Fibrinogen Concentrates
Table 8. Major Players of Factor XIII
Table 9. Global Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)
Table 10. Global Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)
Table 11. Global Coagulation Factor Concentrates Revenue by Type (2017-2022) & ($ million)
Table 12. Global Coagulation Factor Concentrates Revenue Market Share by Type (2017-2022)
Table 13. Global Coagulation Factor Concentrates Sale Price by Type (2017-2022) & (USD/Pcs)
Table 14. Global Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)
Table 15. Global Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)
Table 16. Global Coagulation Factor Concentrates Revenue by Application (2017-2022)
Table 17. Global Coagulation Factor Concentrates Revenue Market Share by Application (2017-2022)
Table 18. Global Coagulation Factor Concentrates Sale Price by Application (2017-2022) & (USD/Pcs)
Table 19. Global Coagulation Factor Concentrates Sales by Company (2020-2022) & (K Pcs)
Table 20. Global Coagulation Factor Concentrates Sales Market Share by Company (2020-2022)
Table 21. Global Coagulation Factor Concentrates Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Coagulation Factor Concentrates Revenue Market Share by Company (2020-2022)
Table 23. Global Coagulation Factor Concentrates Sale Price by Company (2020-2022) & (USD/Pcs)
Table 24. Key Manufacturers Coagulation Factor Concentrates Producing Area Distribution and Sales Area
Table 25. Players Coagulation Factor Concentrates Products Offered
Table 26. Coagulation Factor Concentrates Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Coagulation Factor Concentrates Sales by Geographic Region (2017-2022) & (K Pcs)
Table 30. Global Coagulation Factor Concentrates Sales Market Share Geographic Region (2017-2022)
Table 31. Global Coagulation Factor Concentrates Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Coagulation Factor Concentrates Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Coagulation Factor Concentrates Sales by Country/Region (2017-2022) & (K Pcs)
Table 34. Global Coagulation Factor Concentrates Sales Market Share by Country/Region (2017-2022)
Table 35. Global Coagulation Factor Concentrates Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Coagulation Factor Concentrates Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)
Table 38. Americas Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)
Table 39. Americas Coagulation Factor Concentrates Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)
Table 41. Americas Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)
Table 42. Americas Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)
Table 43. Americas Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)
Table 44. Americas Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)
Table 45. APAC Coagulation Factor Concentrates Sales by Region (2017-2022) & (K Pcs)
Table 46. APAC Coagulation Factor Concentrates Sales Market Share by Region (2017-2022)
Table 47. APAC Coagulation Factor Concentrates Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Coagulation Factor Concentrates Revenue Market Share by Region (2017-2022)
Table 49. APAC Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)
Table 50. APAC Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)
Table 51. APAC Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)
Table 52. APAC Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)
Table 53. Europe Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)
Table 54. Europe Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)
Table 55. Europe Coagulation Factor Concentrates Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)
Table 57. Europe Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)
Table 59. Europe Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)
Table 60. Europe Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Coagulation Factor Concentrates Sales by Country (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Coagulation Factor Concentrates Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Coagulation Factor Concentrates Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Coagulation Factor Concentrates Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Coagulation Factor Concentrates Sales by Type (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Coagulation Factor Concentrates Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Coagulation Factor Concentrates Sales by Application (2017-2022) & (K Pcs)
Table 68. Middle East & Africa Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Coagulation Factor Concentrates
Table 70. Key Market Challenges & Risks of Coagulation Factor Concentrates
Table 71. Key Industry Trends of Coagulation Factor Concentrates
Table 72. Coagulation Factor Concentrates Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Coagulation Factor Concentrates Distributors List
Table 75. Coagulation Factor Concentrates Customer List
Table 76. Global Coagulation Factor Concentrates Sales Forecast by Region (2023-2028) & (K Pcs)
Table 77. Global Coagulation Factor Concentrates Sales Market Forecast by Region
Table 78. Global Coagulation Factor Concentrates Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Coagulation Factor Concentrates Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Americas Coagulation Factor Concentrates Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Coagulation Factor Concentrates Sales Forecast by Region (2023-2028) & (K Pcs)
Table 83. APAC Coagulation Factor Concentrates Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Coagulation Factor Concentrates Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Europe Coagulation Factor Concentrates Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Coagulation Factor Concentrates Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Middle East & Africa Coagulation Factor Concentrates Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Coagulation Factor Concentrates Sales Forecast by Type (2023-2028) & (K Pcs)
Table 89. Global Coagulation Factor Concentrates Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Coagulation Factor Concentrates Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Coagulation Factor Concentrates Sales Forecast by Application (2023-2028) & (K Pcs)
Table 93. Global Coagulation Factor Concentrates Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Coagulation Factor Concentrates Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Application (2023-2028)
Table 96. CSL (Australia) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 97. CSL (Australia) Coagulation Factor Concentrates Product Offered
Table 98. CSL (Australia) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 99. CSL (Australia) Main Business
Table 100. CSL (Australia) Latest Developments
Table 101. Grifols (Spain) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 102. Grifols (Spain) Coagulation Factor Concentrates Product Offered
Table 103. Grifols (Spain) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 104. Grifols (Spain) Main Business
Table 105. Grifols (Spain) Latest Developments
Table 106. Shire (Ireland) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 107. Shire (Ireland) Coagulation Factor Concentrates Product Offered
Table 108. Shire (Ireland) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 109. Shire (Ireland) Main Business
Table 110. Shire (Ireland) Latest Developments
Table 111. Octapharma (Switzerland) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 112. Octapharma (Switzerland) Coagulation Factor Concentrates Product Offered
Table 113. Octapharma (Switzerland) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 114. Octapharma (Switzerland) Main Business
Table 115. Octapharma (Switzerland) Latest Developments
Table 116. Kedrion (Italy) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 117. Kedrion (Italy) Coagulation Factor Concentrates Product Offered
Table 118. Kedrion (Italy) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 119. Kedrion (Italy) Main Business
Table 120. Kedrion (Italy) Latest Developments
Table 121. Bio Product Laboratory (UK) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 122. Bio Product Laboratory (UK) Coagulation Factor Concentrates Product Offered
Table 123. Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 124. Bio Product Laboratory (UK) Main Business
Table 125. Bio Product Laboratory (UK) Latest Developments
Table 126. Sanquin (Netherlands) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 127. Sanquin (Netherlands) Coagulation Factor Concentrates Product Offered
Table 128. Sanquin (Netherlands) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 129. Sanquin (Netherlands) Main Business
Table 130. Sanquin (Netherlands) Latest Developments
Table 131. LFB (France) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 132. LFB (France) Coagulation Factor Concentrates Product Offered
Table 133. LFB (France) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 134. LFB (France) Main Business
Table 135. LFB (France) Latest Developments
Table 136. Biotest (Germany) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 137. Biotest (Germany) Coagulation Factor Concentrates Product Offered
Table 138. Biotest (Germany) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 139. Biotest (Germany) Main Business
Table 140. Biotest (Germany) Latest Developments
Table 141. Japan Blood Products Organization, China Biologic Products (China) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 142. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Product Offered
Table 143. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 144. Japan Blood Products Organization, China Biologic Products (China) Main Business
Table 145. Japan Blood Products Organization, China Biologic Products (China) Latest Developments
Table 146. Green Cross Corporation (South Korea) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 147. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Product Offered
Table 148. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 149. Green Cross Corporation (South Korea) Main Business
Table 150. Green Cross Corporation (South Korea) Latest Developments
Table 151. Shanghai RAAS Blood Products (China) Basic Information, Coagulation Factor Concentrates Manufacturing Base, Sales Area and Its Competitors
Table 152. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Product Offered
Table 153. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 154. Shanghai RAAS Blood Products (China) Main Business
Table 155. Shanghai RAAS Blood Products (China) Latest Developments

LIST OF FIGURES

Figure 1. Picture of Coagulation Factor Concentrates
Figure 2. Coagulation Factor Concentrates Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Coagulation Factor Concentrates Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Coagulation Factor Concentrates Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Coagulation Factor Concentrates Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Factor VIII
Figure 10. Product Picture of Factor IX
Figure 11. Product Picture of Von Willebrand Factor
Figure 12. Product Picture of Prothrombin Complex Concentrates
Figure 13. Product Picture of Fibrinogen Concentrates
Figure 14. Product Picture of Factor XIII
Figure 15. Global Coagulation Factor Concentrates Sales Market Share by Type in 2021
Figure 16. Global Coagulation Factor Concentrates Revenue Market Share by Type (2017-2022)
Figure 17. Coagulation Factor Concentrates Consumed in Neurology
Figure 18. Global Coagulation Factor Concentrates Market: Neurology (2017-2022) & (K Pcs)
Figure 19. Coagulation Factor Concentrates Consumed in Immunology
Figure 20. Global Coagulation Factor Concentrates Market: Immunology (2017-2022) & (K Pcs)
Figure 21. Coagulation Factor Concentrates Consumed in Hematology
Figure 22. Global Coagulation Factor Concentrates Market: Hematology (2017-2022) & (K Pcs)
Figure 23. Coagulation Factor Concentrates Consumed in Critical Care
Figure 24. Global Coagulation Factor Concentrates Market: Critical Care (2017-2022) & (K Pcs)
Figure 25. Coagulation Factor Concentrates Consumed in Pulmonology
Figure 26. Global Coagulation Factor Concentrates Market: Pulmonology (2017-2022) & (K Pcs)
Figure 27. Coagulation Factor Concentrates Consumed in Hemato-Oncology
Figure 28. Global Coagulation Factor Concentrates Market: Hemato-Oncology (2017-2022) & (K Pcs)
Figure 29. Coagulation Factor Concentrates Consumed in Rheumatology
Figure 30. Global Coagulation Factor Concentrates Market: Rheumatology (2017-2022) & (K Pcs)
Figure 31. Coagulation Factor Concentrates Consumed in Others
Figure 32. Global Coagulation Factor Concentrates Market: Others (2017-2022) & (K Pcs)
Figure 33. Global Coagulation Factor Concentrates Sales Market Share by Application (2017-2022)
Figure 34. Global Coagulation Factor Concentrates Revenue Market Share by Application in 2021
Figure 35. Coagulation Factor Concentrates Revenue Market by Company in 2021 ($ Million)
Figure 36. Global Coagulation Factor Concentrates Revenue Market Share by Company in 2021
Figure 37. Global Coagulation Factor Concentrates Sales Market Share by Geographic Region (2017-2022)
Figure 38. Global Coagulation Factor Concentrates Revenue Market Share by Geographic Region in 2021
Figure 39. Global Coagulation Factor Concentrates Sales Market Share by Region (2017-2022)
Figure 40. Global Coagulation Factor Concentrates Revenue Market Share by Country/Region in 2021
Figure 41. Americas Coagulation Factor Concentrates Sales 2017-2022 (K Pcs)
Figure 42. Americas Coagulation Factor Concentrates Revenue 2017-2022 ($ Millions)
Figure 43. APAC Coagulation Factor Concentrates Sales 2017-2022 (K Pcs)
Figure 44. APAC Coagulation Factor Concentrates Revenue 2017-2022 ($ Millions)
Figure 45. Europe Coagulation Factor Concentrates Sales 2017-2022 (K Pcs)
Figure 46. Europe Coagulation Factor Concentrates Revenue 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Coagulation Factor Concentrates Sales 2017-2022 (K Pcs)
Figure 48. Middle East & Africa Coagulation Factor Concentrates Revenue 2017-2022 ($ Millions)
Figure 49. Americas Coagulation Factor Concentrates Sales Market Share by Country in 2021
Figure 50. Americas Coagulation Factor Concentrates Revenue Market Share by Country in 2021
Figure 51. United States Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 52. Canada Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 53. Mexico Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 54. Brazil Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 55. APAC Coagulation Factor Concentrates Sales Market Share by Region in 2021
Figure 56. APAC Coagulation Factor Concentrates Revenue Market Share by Regions in 2021
Figure 57. China Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 58. Japan Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Korea Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 60. Southeast Asia Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 61. India Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 62. Australia Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 63. Europe Coagulation Factor Concentrates Sales Market Share by Country in 2021
Figure 64. Europe Coagulation Factor Concentrates Revenue Market Share by Country in 2021
Figure 65. Germany Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 66. France Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 67. UK Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 68. Italy Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 69. Russia Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 70. Middle East & Africa Coagulation Factor Concentrates Sales Market Share by Country in 2021
Figure 71. Middle East & Africa Coagulation Factor Concentrates Revenue Market Share by Country in 2021
Figure 72. Egypt Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 73. South Africa Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 74. Israel Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 75. Turkey Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 76. GCC Country Coagulation Factor Concentrates Revenue Growth 2017-2022 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Coagulation Factor Concentrates in 2021
Figure 78. Manufacturing Process Analysis of Coagulation Factor Concentrates
Figure 79. Industry Chain Structure of Coagulation Factor Concentrates
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles


More Publications